In order to appropriately determine a patient’s ovarian cancer risk (and thus their eligibility or indication for oophorectomy), a full evaluation should be performed including genetic testing, gathering of family history, pelvic imaging if the patient is symptomatic, and hormone receptor status of breast cancer. This evidence concerns the gene NR4A1 and breast cancer.